Islam Saqib Acquires 30,000 Stock Options in ARS Pharmaceuticals, Inc.

On June 24, 2026, Islam Saqib, a director at ARS Pharmaceuticals, Inc. (SPRY), acquired 30,000 stock options. The options have an exercise price of $10.54 and are exercisable until June 23, 2036. These options will vest in full on the earlier of June 24, 2027, or the date of the Issuer's 2027 annual meeting of stockholders. Following this acquisition, Mr. Saqib directly owns 30,000 shares underlying these options. The transaction was reported on Form 4, filed on June 26, 2026.